Clinical Trial: LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Multicentre, Double-blind, Parallel, Randomized, Placebo-controlled Study : Evaluation of the Efficacy and Safety of Levocetirizine 5 mg and Desloratadine 5 mg Administered Orally as Capsules Once D

Brief Summary: Two weeks study to evaluate the efficacy and safety of Levocetirizine and Desloratadine in patients suffering from Allergic Rhinitis (AR)